Skip to content

Clinical trials

HIV Seropositivity trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: HIV Seropositivity Clear all

194 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20012
20022
20031
20044
20057
200612
20074
200810
20096
20107
20118
20128
201312
20146
20159
20165
20178
20187
20197
202015
202112
20227
20239
20242
20257

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed146
Unknown status21
Terminated10
Active, not recruiting5
Recruiting5
Not yet recruiting3
Withdrawn3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)16
University of Washington6
ANRS, Emerging Infectious Diseases5
University of North Carolina, Chapel Hill5
Centers for Disease Control and Prevention3
Fondation Ophtalmologique Adolphe de Rothschild3
National Cancer Institute (NCI)3
University Hospital, Ghent3
University of California, San Diego3
Wayne State University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
HIV Seropositivity194
HIV Infections54
Acquired Immunodeficiency Syndrome30
COVID-199
Diarrhea5
AIDS-Related Complex4
Hepatitis C4
Opioid-Related Disorders4
Poliomyelitis4
Sexually Transmitted Diseases4

Trials

Showing 51 to 75 of 194. Each trial links to its page on Pharma Observatory.

94 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.